Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride effectively treats hair loss in transgender men with few side effects.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

There is no significant link between male pattern baldness and insulin resistance.

Testosterone therapy and surgeries like mastectomy improve transgender men's lives and mental health with low risks and high satisfaction.

BMI is not a significant predictor of complications after gender-affirming penile inversion vaginoplasty.

The document concludes that health care providers should offer culturally competent care and more research is needed to improve health outcomes for transgender individuals.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

In Japan, sex reassignment surgery for gender identity disorder faces challenges and needs better medical support and education.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Early medical support for transgender youth is important for their health, with low regret for gender-affirming hormone use and a need for knowledgeable care providers.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Healthcare providers need better education and policies to serve transgender individuals effectively.

Older obese women with PCOS have higher cardiovascular and metabolic risks despite lower androgen levels.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Most insurance companies do not cover extra gender-affirming surgeries, with coverage being low and inconsistent.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

No clear link between hair loss and metabolic syndrome, but some differences in blood pressure and glucose levels.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.